EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Extensive adeno carcinoma and large cell undifferentiated carcinoma of the lung treated with 5 fluoro uracil vindesine and mitomycin a southwest oncology group usa study






Cancer Treatment Reports 66(3): 553-556

Extensive adeno carcinoma and large cell undifferentiated carcinoma of the lung treated with 5 fluoro uracil vindesine and mitomycin a southwest oncology group usa study

Sixty-three previously untreated patients with metastatic non-small cell lung cancer (40 patients with adenocarcinoma and 23 with large cell undifferentiated carcinoma) were treated with combination chemotherapy consisting of 5-FU [5-fluorouracil] (300 mg/m2) given as an i.v. bolus on Days 1-4 and vindesine (3 mg/m2) and mitomycin (10 mg/m2), both given as an i.v. bolus on Day 1 of each treatment course (FEMi). FEMi was repeated at 3-wk intervals for 3 treatment courses and thereafter at 6-wk intervals until disease progression. Major objective responses were seen in 13 of the 63 patients (21%). Minor responses were seen in an additional 12 patients (19%). The median survival for all patients was 23 wk and for responding patients was 38 wk. The pretreatment performance status had a significant effect on the response rate and survival time. Patients having an initial Karnofsky performance score .gtoreq. 70% had a 54% response rate, with a median survival of 42 wk for responding patients. FEMi was well tolerated; 18 patients (29%) did not have any side effects and only five (8%) experienced vomiting.


Accession: 005432915



Related references

Extensive adenocarcinoma and large cell undifferentiated carcinoma of the lung treated with 5-FU, vindesine, and mitomycin (FEMi): a Southwest Oncology Group Study. Cancer Treatment Reports 66(3): 553-556, 1982

Extensive adeno carcinoma and large cell undifferentiated carcinoma of the lung treated with 5 fluoro uracil vincristine and mitomycin c. Proceedings of the American Association for Cancer Research & American Society of Clinical Oncology 21: 453, 1980

Treatment of advanced adeno carcinoma and large cell undifferentiated carcinoma of the lung with 5 fluoro uracil vincristine or vindesine and mitomycin c a preliminary analysis. Brade, W , G A Nagel And S Seeber (Ed ) Beitraege Zur Onkologie, Contributions to Oncology, Vol 6 Proceedings Of The International Vinca Alkaloid Symposium: Vindesine; Joint Event Of Arbeitsgemeinschaft Internistische Onkologie Der Deutschen Krebsgesellschaft (Internal Oncology Working Group Of The German Cancer Society) And Eli Lilly Gmbh, Germany, Frankfurt Am Main, West Germany, Nov 1980 Xii+458p S Karger: Basel, Switzerland; New York, N Y , Usa Illus Paper P356-362, 1981

Randomized comparison of 5 fluoro uracil and mitomycin c vs 5 fluoro uracil mitomycin c and streptozotocin in pancreatic adeno carcinoma a southwest oncology group usa study. 1981

Combination chemo therapy of advanced adeno carcinoma and large cell undifferentiated carcinoma of the lung with 5 fluoro uracil vincristine and mitomycin c. Proceedings of the American Association for Cancer Research & American Society of Clinical Oncology 21: 453, 1980

Extensive non small cell lung cancer treated with mitomycin cisplatin and vindesine a southwest usa oncology group study. Cancer Treatment Reports 70(9): 1101-1104, 1986

Extensive non-small cell lung cancer treated with mitomycin, cisplatin, and vindesine (MiPE): a Southwest Oncology Group Study. Cancer Treatment Reports 70(9): 1101-1104, 1986

Extensive adenocarcinoma and large cell undifferentiated carcinoma of the lung treated with 5-FU, vincristine, and mitomycin C (FOMi). Cancer Treatment Reports 64(12): 1241-1245, 1980

5 fluoro uracil 1 2 chloroethyl 3 4 methylcyclohexyl 1 nitroso urea and radio therapy with or without testo lactone for localized adeno carcinoma of the exocrine pancreas a southwest oncology group study. Cancer 46(7): 1518-1522, 1980

Simultaneous chemotherapy-radiotherapy with prophylactic cranial irradiation for inoperable adeno and large cell lung carcinoma: a Southwest Oncology Group Study. International Journal of Radiation Oncology, Biology, Physics 15(3): 757-761, 1988